{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"438"},{"groupId":"OG001","value":"432"}],"units":"Participants"}],"title":"Pre-treatment deaths"},{"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"435"},{"groupId":"OG001","value":"432"}],"units":"Participants"}],"title":"On-treatment deaths"},{"categories":[{"measurements":[{"groupId":"OG000","value":"121"},{"groupId":"OG001","value":"135"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"431"},{"groupId":"OG001","value":"431"}],"units":"Participants"}],"title":"Post-treatment deaths"},{"categories":[{"measurements":[{"groupId":"OG000","value":"125"},{"groupId":"OG001","value":"136"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"438"},{"groupId":"OG001","value":"432"}],"units":"Participants"}],"title":"All deaths"}],"denoms":[{"counts":[{"groupId":"OG000","value":"438"},{"groupId":"OG001","value":"432"}],"units":"Participants"}],"description":"Pre-treatment deaths were collected from day of participant's informed consent to the day before first dose of study medication.\n\nOn-treatment deaths were collected from first dose of study treatment to 30 days after last dose of study medication (on-treatment), up to approximately 12 months.\n\nDeaths were collected in the post treatment survival follow up from 31 days after last dose of study medication until the end of the study, up to approximately 126 months.","groups":[{"description":"Subjects received dabrafenib (150 mg twice daily) and trametinib (2 mg once daily) orally for 12 months.","id":"OG000","title":"Dabrafenib and Trametinib Combination Therapy"},{"description":"Subjects received matching placebos orally for 12 months","id":"OG001","title":"Dabrafenib and Trametinib Placebos"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Intent-to-Treat (ITT) Population","reportingStatus":"POSTED","timeFrame":"Pre-treatment deaths: Up to 28 days prior to treatment. On-treatment deaths: Up to approximately 12 months. Post-treatment deaths: Up to approximately 126 months","title":"All Collected Deaths","type":"POST_HOC","unitOfMeasure":"Participants"}